查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493325

美国IVF 市场规模、份额和趋势分析报告：按设备、程序类型、最终用途和细分市场进行预测，2024-2030 年

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国试管婴儿市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2024年至2030年美国IVF市场规模将以4.4%的复合年增长率成长，2030年将达到72.4亿美元。

婚姻不孕症的日益普遍、体外受精技术和方法的不断进步以及社会规范和对家庭的态度的变化是美国对体外受精服务需求增加的主要原因。

围绕辅助生殖技术（包括体外受精）的监管环境也在影响市场动态。管理 IVF 实践、诊所认证标准和道德考虑的法规影响着美国IVF 服务的可及性和品质。监管变化可以透过影响治疗成本、诊所运作和病人安全等因素来促进或阻碍市场成长。

提高大众对不孕症问题和可用治疗方法的认识在推动美国试管婴儿市场的成长中发挥关键作用。教育宣传活动、媒体报导和宣传工作正在帮助使不孕症变得非人性化，并促进对体外受精等不孕症治疗的理解。随着认识的提高，人们现在可以就透过体外受精治疗不孕症做出明智的决定。

美国试管婴儿市场报告亮点

  • 从设备来看，文化传媒领域将在2023年占据市场主导地位，份额约40%。
  • 抛弃式设备领域预计在预测期内将以最快的复合年增长率成长。
  • 根据手术类型，新鲜的非捐赠者细分市场占据最大市场占有率，到 2023 年将超过 45%。新鲜週期通常被认为具有成本效益，因为实现成功怀孕可能需要更少的治疗週期。
  • 由于其便利性和灵活性，冷冻捐赠者预计在预测期内将实现最快的复合年增长率。
  • 2023年，生育诊所市场约占80%的份额，预计在预测期内将以最快的复合年增长率成长。
  • 对 ART 治疗的需求不断增加，导致生育诊所和 ART 中心的数量大幅增加。
  • 2023年10月，默克公司宣布启动生育福利计划，旨在为员工提供生育治疗的金融服务。服务范围包括体外受精治疗、不孕症测试和荷尔蒙治疗。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国IVF 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国IVF市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国试管婴儿市场：设备估算及趋势分析

  • 2023年及2030年设备市场占有率
  • 细分仪表板
  • 按设备分類的美国IVF 市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 抛弃式培养基
  • 培养基
  • 主要设备

第五章美国IVF市场：治疗类型估算及趋势分析

  • 2023 年和 2030 年按治疗类型市场占有率
  • 细分仪表板
  • 美国IVF 市场：依手术类型分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 新的捐赠者
  • 冷冻供体
  • 新鲜的非捐赠者
  • 冷冻非捐赠者

第六章美国IVF 市场：最终用途估算与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国IVF 市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 设施诊所
  • 医院及其他环境

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Bayer AG
    • Cook Medical LLC
    • EMD Serono, Inc.
    • Ferring BV
    • FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation）
    • Genea Biomedx
    • EMD Serono, Inc.（Merck KGaA）
    • Merck &Co., Inc.
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Vitrolife
    • Nova IVF
    • RMA Network（Reproductive Medicine Associates）
    • US Fertility
Product Code: GVR-4-68040-278-5

U.S. In Vitro Fertilization Market Growth & Trends:

The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.

The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.

Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.

U.S. In Vitro Fertilization Market Report Highlights:

  • Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
  • The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
  • Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
  • Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
  • The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
  • In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Instrument
    • 1.2.2. Procedure type
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Instrument outlook
    • 2.2.2. Procedure type
    • 2.2.3. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. In Vitro Fertilization Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis

  • 4.1. Instrument Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Disposable media
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Culture media
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Cryopreservation Media
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Embryo culture media
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Ovum Processing Media
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Sperm Processing Media
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Capital Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Sperm Analyzer Systems
      • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Imaging Systems
      • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Ovum Aspiration Pumps
      • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Micromanipulator Systems
      • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Incubators
      • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.7. Gas Analyzers
      • 4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.8. Laser Systems
      • 4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.9. Cryosystems
      • 4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.10. Sperm Separation Devices
      • 4.4.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.11. IVF Cabinets
      • 4.4.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.12. Anti-vibration Tables
      • 4.4.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.13. Witness Systems
      • 4.4.3.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.14. Other
      • 4.4.3.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Procedure Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Fresh Donor
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Frozen Donor
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Fresh Non-donor
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Frozen Non-donor
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. In Vitro Fertilization Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Fertility Clinics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Hospitals & Others Setting
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Bayer AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Cook Medical LLC
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. EMD Serono, Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Ferring B.V.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Genea Biomedx
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. EMD Serono, Inc. (Merck KGaA)
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Merck & Co., Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. The Cooper Companies, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Thermo Fisher Scientific, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Vitrolife
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Nova IVF
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiativesc
    • 7.4.13. RMA Network (Reproductive Medicine Associates)
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. U.S. Fertility
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. in vitro fertilization market, by instrument, 2018 - 2030 (USD Million)
  • Table 3 U.S. in vitro fertilization market, by procedure type, 2018 - 2030 (USD Million)
  • Table 4 U.S. in vitro fertilization market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. in vitro fertilization market: market outlook
  • Fig. 9 U.S. in vitro fertilization competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. in vitro fertilization market driver impact
  • Fig. 14 U.S. in vitro fertilization market restraint impact
  • Fig. 15 U.S. in vitro fertilization market: Instrument movement analysis
  • Fig. 16 U.S. in vitro fertilization market: Instrument outlook and key takeaways
  • Fig. 17 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Disposable devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Culture Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cryopreservation media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Embryo culture media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Ovum processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Sperm processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Capital equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Sperm analyzer systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Imaging systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ovum aspiration pumps market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Micromanipulator market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Gas analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Laser systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cryosystems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Sperm separation devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 IVF cabinets market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti - vibration tables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Witness systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. in vitro fertilization market: Procedure type movement Analysis
  • Fig. 39 U.S. in vitro fertilization market: Procedure type outlook and key takeaways
  • Fig. 40 Surgical ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Fresh donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Frozen donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Fresh non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Frozen non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. in vitro fertilization market: End - use outlook and key takeaways
  • Fig. 46 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals and other settings market estimates and forecasts, 2018 - 2030 (USD Million)